T. Dong

HLA-E–restricted SARS-CoV-2–specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
202317 citationsauthor #26
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages
202312 citationsauthor #14
Group A streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation
202311 citationsauthor #10
Biopanning of specific peptide for SARS-CoV-2 nucleocapsid protein and enzyme-linked immunosorbent assay-based antigen assay
202316 citationsauthor #7
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
202330 citationsauthor #32
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
202224 citationsauthor #87
Dengue virus co-opts innate type 2 pathways to escape early control of viral replication
202219 citationsauthor #12
Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation
20224 citationsauthor #14
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
202212 citationsauthor #16
Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors
20224 citationsauthor #7
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study
2022123 citationsauthor #18
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles
202248 citationsauthor #13
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design
20221 citationsauthor #7
HIV-1–Specific Immunodominant T-Cell Responses Drive the Dynamics of HIV-1 Recombination Following Superinfection
20222 citationsauthor #8
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design
20220 citationsauthor #7
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka
20229 citationsauthor #29
Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control
20222 citationsauthor #1
SARS-CoV-2 mutations affect proteasome processing to alter CD8+ T cell responses
20224 citationsauthor #15
Antibody evasion by the P.1 strain of SARS-CoV-2
2021542 citationsauthor #26
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
202116 citationsauthor #17
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
202111 citationsauthor #15
Antibody and T-cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naive health care workers in Sri Lanka
20219 citationsauthor #25
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
202130 citationsauthor #87
Clonotypic architecture of a Gag‐specific CD8+ T‐cell response in chronic human HIV‐2 infection
20210 citationsauthor #12
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
2021275 citationsauthor #49
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
202112 citationsauthor #27
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
2021141 citationsauthor #76
Synthetic antigen-presenting cells reveal the diversity and functional specialisation of extracellular vesicles composing the fourth signal of T cell immunological synapses
20211 citationsauthor #13
Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2
202134 citationsauthor #27
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
20217 citationsauthor #271
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
202183 citationsauthor #19
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals
20215 citationsauthor #24
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals in Sri Lanka
202136 citationsauthor #28
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals
202129 citationsauthor #28
Promises and challenges of adoptive T-cell therapies for solid tumours
2021179 citationsauthor #7
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
20210 citationsauthor #15
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
2021735 citationsauthor #29
The antigenic anatomy of SARS-CoV-2 receptor binding domain
2021357 citationsauthor #32
PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer
202116 citationsauthor #10
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation
202118 citationsauthor #11
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2
202115 citationsauthor #4
Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity
20217 citationsauthor #32
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
20211,002 citationsauthor #24
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
20214 citationsauthor #17
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
202179 citationsauthor #66
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
202169 citationsauthor #66
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
202189 citationsauthor #17
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
202146 citationsauthor #25
Single-Molecule, Super-Resolution, and Functional Analysis of G Protein-Coupled Receptor Behavior Within the T Cell Immunological Synapse
202116 citationsauthor #8
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
2021432 citationsauthor #32
IFITM3 regulates virus-induced inflammatory cytokine production by titrating Nogo-B orchestration of TLR responses
20212 citationsauthor #19
Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma
20216 citationsauthor #6
The Antigenic Anatomy of SARS-CoV-2 Receptor Binding Domain
2020142 citationsauthor #32
Malignancy and IFITM3: Friend or Foe?
202045 citationsauthor #3
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients
2020112 citationsauthor #60
Germline bias dictates cross-serotype reactivity in a common
202027 citationsauthor #14
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
2020125 citationsauthor #20
Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease.
2020380 citationsauthor #21
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments
202010 citationsauthor #19
Clinical and epidemiological features of COVID-19 family clusters in Beijing, China
202084 citationsauthor #6
A Novel Scoring System for Prediction of Disease Severity in COVID-19
2020105 citationsauthor #14
Human cancer germline antigen-specific cytotoxic T cell—what can we learn from patient
202016 citationsauthor #3
Human cancer germline antigen-specific cytotoxic T cell—what can we learn from patient
20201 citationsauthor #3
IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models
202024 citationsauthor #14
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2020293 citationsauthor #113
IFITM3‐specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans
20206 citationsauthor #16
Defective Interferon Gamma Production by Tumor-Specific CD8+ T Cells Is Associated With 5′Methylcytosine-Guanine Hypermethylation of Interferon Gamma Promoter
202011 citationsauthor #9
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019
2020149 citationsauthor #15
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
2020490 citationsauthor #271
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
2020382 citationsauthor #32
IFITM3: How genetics influence influenza infection demographically
201943 citationsauthor #4
High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China
20199 citationsauthor #9
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses
201942 citationsauthor #17
Low basal expression and slow induction of IFITM3 puts immune cells at risk of influenza A infection
20193 citationsauthor #14
Author response: Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells
20191 citationsauthor #10
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses
201964 citationsauthor #18
The impact of an updated pandemic H1N1 strain on shedding and immunogenicity to Russian-backbone live attenuated influenza vaccine among children in The Gambia: an open-label, observational, phase 4 study
20192 citationsauthor #14
Elevated CD54 expression renders CD4+ T cells susceptible to NK cell-mediated killing.
20195 citationsauthor #10
Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma
20198 citationsauthor #10
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study
201939 citationsauthor #14
Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells
201963 citationsauthor #10
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
201955 citationsauthor #28
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans
201934 citationsauthor #6
T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell
20193 citationsauthor #8
The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection
201828 citationsauthor #9
1663. Marked Improvement in Pandemic H1N1 Component Shedding and Immunogenicity in 2017–2018 Russian-Backbone Live Attenuated Influenza Vaccine (LAIV) in Gambian Children
20180 citationsauthor #11
Activated innate lymphoid cell populations accumulate in human tumour tissues
20183 citationsauthor #9
HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation
20188 citationsauthor #10
Distribution of HLA-A alleles and its relation to clinical outcome in Uyghur and Han patients with advanced squamous cell cervical cancer in Xinjiang, China
20181 citationsauthor #8
Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome
201810 citationsauthor #6
MiR-128-3p increases sensitivity of hepatoma cells to oxaliplatin by targeting Lin28B
20180 citationsauthor #4
Archives of Gynecology and Obstetrics Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome
20180 citationsauthor #6
Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma
201811 citationsauthor #6
Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection
201824 citationsauthor #4
High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults
201813 citationsauthor #12
Structure–function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans
201849 citationsauthor #6
Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak
20183 citationsauthor #3
HLA-A*30:01 and HLA-A*33:03 are the protective alleles while HLA-A*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China
20185 citationsauthor #3
Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood
20180 citationsauthor #7
Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection
201845 citationsauthor #17

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT